All In MedTech

FDA Clearance Tracker · P020027-S028

Dimension FPSA Flex Reagent Cartridge

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 13, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 13, 2018

Approved

Time to decision

200 days

Received Sep 25, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P020027-S028
Device name
Dimension FPSA Flex Reagent Cartridge
Applicant location
Newark, DE
Received
Sep 25, 2017
Decided
Apr 13, 2018
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P020027

Device type

Device class
Class III

Every decision under product code MTG

FDA's approval statement

As written in FDA's record.

Approval of the instrument manufacturing site change for the Dimension® EXL integrated systems to the Siemens instrument manufacturing facility located in Flanders, New Jersey.

Source documents

Other decisions for Siemens Healthcare Diagnostics

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.